SG11202106965RA - Substituted polycyclic carboxylic acids, analogues thereof, and methods using same - Google Patents
Substituted polycyclic carboxylic acids, analogues thereof, and methods using sameInfo
- Publication number
- SG11202106965RA SG11202106965RA SG11202106965RA SG11202106965RA SG11202106965RA SG 11202106965R A SG11202106965R A SG 11202106965RA SG 11202106965R A SG11202106965R A SG 11202106965RA SG 11202106965R A SG11202106965R A SG 11202106965RA SG 11202106965R A SG11202106965R A SG 11202106965RA
- Authority
- SG
- Singapore
- Prior art keywords
- analogues
- methods
- same
- carboxylic acids
- substituted polycyclic
- Prior art date
Links
- -1 polycyclic carboxylic acids Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7105—Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962793578P | 2019-01-17 | 2019-01-17 | |
| PCT/US2020/013701 WO2020150366A1 (en) | 2019-01-17 | 2020-01-15 | Substituted polycyclic carboxylic acids, analogues thereof, and methods using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202106965RA true SG11202106965RA (en) | 2021-08-30 |
Family
ID=71613992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202106965RA SG11202106965RA (en) | 2019-01-17 | 2020-01-15 | Substituted polycyclic carboxylic acids, analogues thereof, and methods using same |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20220125771A1 (https=) |
| EP (1) | EP3911653A4 (https=) |
| JP (1) | JP2022518456A (https=) |
| KR (1) | KR20210121044A (https=) |
| CN (1) | CN113825756A (https=) |
| AU (1) | AU2020208371A1 (https=) |
| BR (1) | BR112021014079A2 (https=) |
| CA (1) | CA3126102A1 (https=) |
| EA (1) | EA202191967A1 (https=) |
| IL (1) | IL284845A (https=) |
| MX (1) | MX2021008646A (https=) |
| PH (1) | PH12021551718A1 (https=) |
| SG (1) | SG11202106965RA (https=) |
| TW (1) | TW202033523A (https=) |
| WO (1) | WO2020150366A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10952978B2 (en) | 2017-08-28 | 2021-03-23 | Enanta Pharmaceuticals, Inc. | Hepatitis B antiviral agents |
| US11702427B2 (en) | 2018-03-12 | 2023-07-18 | Arbutus Biopharma Corporation | Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same |
| CN110862390B (zh) | 2018-08-28 | 2023-05-09 | 广东东阳光药业有限公司 | 稠合三环类化合物及其在药物中的应用 |
| UY38383A (es) | 2018-09-21 | 2020-04-30 | Enanta Pharm Inc | Heterociclos funcionalizados como agentes antivirales |
| CA3111046A1 (en) | 2018-09-30 | 2020-04-02 | Sunshine Lake Pharma Co., Ltd. | Fused tetracyclic compounds and uses thereof in medicine |
| US11198693B2 (en) | 2018-11-21 | 2021-12-14 | Enanta Pharmaceuticals, Inc. | Functionalized heterocycles as antiviral agents |
| US11738019B2 (en) | 2019-07-11 | 2023-08-29 | Enanta Pharmaceuticals, Inc. | Substituted heterocycles as antiviral agents |
| US11236108B2 (en) * | 2019-09-17 | 2022-02-01 | Enanta Pharmaceuticals, Inc. | Functionalized heterocycles as antiviral agents |
| WO2021188414A1 (en) | 2020-03-16 | 2021-09-23 | Enanta Pharmaceuticals, Inc. | Functionalized heterocyclic compounds as antiviral agents |
| TW202304914A (zh) * | 2021-04-05 | 2023-02-01 | 加拿大商愛彼特生物製藥公司 | 經取代之四環羧酸、其類似物及使用其之方法 |
| WO2024038357A1 (en) * | 2022-08-16 | 2024-02-22 | Arbutus Biopharma Corporation | Synthesis of substituted tetracyclic carboxylic acids and analogues thereof |
| CN115819200B (zh) * | 2022-11-28 | 2023-08-29 | 辽宁科技学院 | 一种苊醌的合成方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA111756C2 (uk) * | 2011-11-03 | 2016-06-10 | Ф. Хоффманн-Ля Рош Аг | Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона |
| WO2014121416A1 (en) * | 2013-02-07 | 2014-08-14 | Merck Sharp & Dohme Corp. | Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c |
| JP6506880B2 (ja) * | 2015-07-27 | 2019-04-24 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | Ｂ型肝炎ウィルス感染症の治療および予防のための新規な四環式４−オキソ−ピリジン−３−カルボン酸誘導体 |
| US20200270265A1 (en) * | 2016-02-19 | 2020-08-27 | Novartis Ag | Tetracyclic pyridone compounds as antivirals |
| WO2018073753A1 (en) * | 2016-10-18 | 2018-04-26 | Novartis Ag | Fused tetracyclic pyridone compounds as antivirals |
| AR111419A1 (es) * | 2017-04-27 | 2019-07-10 | Novartis Ag | Compuestos fusionados de indazol piridona como antivirales |
| CN110066278B (zh) * | 2017-06-01 | 2021-06-08 | 广东东阳光药业有限公司 | 稠合三环类化合物及其在药物中的应用 |
| TWI815887B (zh) * | 2018-05-15 | 2023-09-21 | 美商愛彼特生物製藥股份有限公司 | 經取代的2,2'-雙嘧啶基化合物、其類似物及其使用方法 |
-
2020
- 2020-01-10 TW TW109100934A patent/TW202033523A/zh unknown
- 2020-01-15 JP JP2021541219A patent/JP2022518456A/ja active Pending
- 2020-01-15 BR BR112021014079-4A patent/BR112021014079A2/pt not_active IP Right Cessation
- 2020-01-15 MX MX2021008646A patent/MX2021008646A/es unknown
- 2020-01-15 EP EP20742028.2A patent/EP3911653A4/en not_active Withdrawn
- 2020-01-15 WO PCT/US2020/013701 patent/WO2020150366A1/en not_active Ceased
- 2020-01-15 US US17/423,151 patent/US20220125771A1/en not_active Abandoned
- 2020-01-15 EA EA202191967A patent/EA202191967A1/ru unknown
- 2020-01-15 CN CN202080016321.4A patent/CN113825756A/zh active Pending
- 2020-01-15 CA CA3126102A patent/CA3126102A1/en active Pending
- 2020-01-15 AU AU2020208371A patent/AU2020208371A1/en not_active Abandoned
- 2020-01-15 SG SG11202106965RA patent/SG11202106965RA/en unknown
- 2020-01-15 PH PH1/2021/551718A patent/PH12021551718A1/en unknown
- 2020-01-15 KR KR1020217023731A patent/KR20210121044A/ko not_active Ceased
-
2021
- 2021-07-14 IL IL284845A patent/IL284845A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3911653A1 (en) | 2021-11-24 |
| WO2020150366A1 (en) | 2020-07-23 |
| AU2020208371A1 (en) | 2021-07-15 |
| CN113825756A (zh) | 2021-12-21 |
| KR20210121044A (ko) | 2021-10-07 |
| EP3911653A4 (en) | 2022-11-02 |
| PH12021551718A1 (en) | 2022-03-28 |
| MX2021008646A (es) | 2021-10-26 |
| BR112021014079A2 (pt) | 2021-09-21 |
| IL284845A (en) | 2021-08-31 |
| JP2022518456A (ja) | 2022-03-15 |
| CA3126102A1 (en) | 2020-07-23 |
| EA202191967A1 (ru) | 2021-10-07 |
| US20220125771A1 (en) | 2022-04-28 |
| TW202033523A (zh) | 2020-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL284845A (en) | Modified polycyclic carboxylic acids, their analogs and methods of using them | |
| IL279830A (en) | -Aryl-4-amino-[0,5,4] bicyclic hydroxamic acids as HDAC inhibitors | |
| SG11201912130RA (en) | Novel aspartokinase variant and method for producing l-amino acid using the same | |
| SG11202001730TA (en) | A novel promoter and a method for producing l-amino acid using the same | |
| EP3200812A4 (en) | Novel 4 7 peptide monomer and dimer antagonists | |
| ZA201906079B (en) | Novel ester compounds, method for the production thereof and use thereof | |
| IL283395A (en) | Arylmethylureas and substituted heteroarylmethylureas, their analogues and their uses | |
| GB201907111D0 (en) | Anchor monitor | |
| ZA201905065B (en) | Novel ester compounds, method for the production thereof and use thereof | |
| ZA202001382B (en) | Novel promoter and l-amino acid production method using same | |
| SG11202109305XA (en) | Aniline-based WDR5 Protein-Protein Interaction Inhibitor, Method for Preparing the Same, and Use thereof | |
| EP3153495A4 (en) | Method for producing carboxylic acid anhydride, and method for producing carboxylic acid ester | |
| PL3484855T3 (pl) | Nowy związek benzyloamidowy, sposób jego wytwarzania i środek roztoczobójczy | |
| GB2610328B (en) | Anchor monitor | |
| EP3119875A4 (en) | Microorganisms producing l-amino acids and process for producing l-amino acids using the same | |
| EP3516094A4 (en) | ANODE APPARATUS AND RELATED METHODS | |
| GB201918011D0 (en) | Injector apparatus | |
| GB201917998D0 (en) | Injector apparatus | |
| EP3777618A4 (en) | CARPET AND MANUFACTURING METHOD FOR IT | |
| SI3947859T1 (sl) | Naprava za sidranje | |
| GB201918015D0 (en) | Injector apparatus | |
| EP3682994A4 (en) | ANCHOR BOLT TREATMENT APPARATUS | |
| EP3642347C0 (de) | Verfahren zur herstellung von carbonsäuren unter unsterilen bedingungen | |
| EP3293179A4 (en) | Amide compound and the preparation method and use thereof | |
| IL283658A (en) | The history of carboxylic acid, their preparation and their use |